TripleNegativeBreastCancer相关论文
Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubi
Inhibition of autophagy has been accepted as a promising therapeutic strategy in cancer,but its clinical application is ......
目的:观察内消瘰疬丸联合术前新辅助化疗方案TAC(多西他赛+吡柔比星+环磷酰胺)对三阴性乳腺癌的治疗效果.方法:120例IIB-III期的三......
目的:探讨GATA3、SOX10和p16在三阴性乳腺癌（TNBC）中的表达，并分析其意义及与临床病理之间相关性。方法:采用免疫组化EnVision法检测5......
Purpose :Triple negative breast cancers (TNBCs) have a high mortality rate owing to aggressive proliferation and metasta......
T1-2N0M0 Triple Negative Breast Cancer Treated with Breast Conserving Therapy has Better Survival Co
...
Objective Breast cancer remains the most common malignant tumor and a huge cause of death among women worldwide.Triple n......
A new oridonin analogs CYD-6-28 induces cell cycle G2/M phase arrest and apoptosis in triple negativ
Oridonin, a complexent-kaurane diterpenoid isolated from the traditional Chinese herb Isodon rubescens, has been demonst......
Folic Acid-Functionalized Ultra-Small Nanographene Oxide for Multimodal Nuclide/Optical Molecular Im
Graphene oxide (GO) is an emerging member of carbon-based nanomaterials and has exhibited a great application potentials......
Objective: The triple negative breast cancer patients has higher rates of local reccurence and distant metastasis and po......
...
P53 gene could be a new effective therapeutic target in triple-negative breast cancer:a Meta-analysi
Purpose To explore the relationship between P53 gene and triple-negative breast cancer,and determine that whether P53 ge......
目的探讨三阴性乳腺癌（triple-negative breast cancer, TNBC）患者血清外泌体中微小RNA（microRNA-335-5p, miR-335-5p）和重组人血管内......
目的探讨肿瘤浸润淋巴细胞(TILs及其表型CD4+TILs、CD8+TILs和FOXP3+TILs对三阴性乳腺癌(TNBC)短期预后[病理完全缓解(PCR)]及长期......
Design,Synthesis and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]
Triple-negative breast cancer(TNBC)is one of the most aggressive and deadly subtypes of breast cancer.[1-3] So far,t......
Pentose Phosphate Pathway as Potentially Important Therapeutic Target for Triple Negative Breast Can
Triple negative breast cancer (TNBC) that lacks the expression of estrogen receptor alpha (ERα), progesterone recep......
三阴性乳腺癌（ TNBC）是乳腺癌的一种临床亚型，具有独特的病理特点和分子生物学特性。由于此类型乳腺癌对放疗、化疗、内分泌治疗效果......
三阴性乳腺癌( TNBC)是雌激素受体、孕激素受体以及人表皮生长因子受体均为阴性的乳腺癌。相对于其他乳腺癌亚型，其具有侵袭性强、......
随着对三阴性乳腺癌( TNBC)分子生物学特征的深入研究，越来越多的潜在治疗靶点及药物也逐渐应用于临床，如以olaparib、veliparib等为......
目的探讨Ki-67表达在三阴性乳腺癌（TNBC）患者预后中的价值。方法用EnVision法检测2013年10月1日至2014年6月30日100例TNBC癌组织中Ki......
三阴性乳腺癌（ TNBC）是一种高度异质性的疾病。因缺乏有效的治疗靶标，故临床预后较差。尽管大量文献报道肿瘤浸润淋巴细胞与TNBC预后......
目的：研究生存素（ survivin）抑制剂YM155对三阴性乳腺细胞株MDA-MB-231的凋亡效应及其可能的作用机制。方法采用CCK-8法实验检测不同......
